Trial Profile
A Double-Blind, Randomised, Multicenter, Phase III Study of Bevacizumab in Combination With Capecitabine and Cisplatin Versus Placebo in Combination With Capecitabine and Cisplatin, as First-Line Therapy in Chinese Patients With Advanced Gastric Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Cisplatin
- Indications Gastric cancer
- Focus Registrational; Therapeutic Use
- Acronyms AVATAR
- Sponsors Roche
- 03 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Oct 2014 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov .
- 14 Oct 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.